Nataliya Milman, University of Ottawa

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study
ACR Open Rheumatology · 2026
The impact of virtual rheumatology care on patient outcomes and hospital admissions: an ambispective study.
BMC rheumatology · 2025
Positive Anti-Glomerular Basement Membrane and Proteinase 3-Antineutrophil Cytoplasmic Autoantibody in Infective Endocarditis-Associated Glomerulonephritis: A Diagnostic Challenge.
Kidney international reports · 2025

All 34 publications

Latest funding

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot
CIHR · 2023 · Co-investigator
$520,200

All 1 grants and awards

34 publications.

01

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

Mendel A, Barra L, Behlouli H, Bernatsky S, Clifford AH, Tervaert JWC, Dehghan N, Fifi‐Mah A, Makhzoum J, Meunier R

ACR Open Rheumatology2026

DOI: 10.1002/acr2.90119

02

The impact of virtual rheumatology care on patient outcomes and hospital admissions: an ambispective study.

Gazel U, Han T, Acikgoz SB, Swami T, Sabido-Sauri R, Goldhar H, Milman N, Maltez N, Ivory C, Humphrey-Murto S, Aydin S

BMC rheumatology2025

DOI: 10.1186/s41927-025-00558-z PMID: 40842030

03

Positive Anti-Glomerular Basement Membrane and Proteinase 3-Antineutrophil Cytoplasmic Autoantibody in Infective Endocarditis-Associated Glomerulonephritis: A Diagnostic Challenge.

Thanabalasingam SJ, Booth RA, Canney M, Milman N, Agostino A, Massicotte-Azarniouch D

Kidney international reports2025

DOI: 10.1016/j.ekir.2025.03.030 PMID: 40630299

04

Glucocorticoid Dosing and Outcomes in ANCA-Associated Vasculitis With Kidney Involvement

Salman M, Canney M, Naidas AM, Derebail VK, Brix SR, Milman N, Junek ML, Akbari A, Walsh M, Massicotte-Azarniouch D

Kidney International Reports20254 citations

DOI: 10.1016/j.ekir.2025.07.022

05

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians

Massicotte-Azarniouch D, Canney M, Karnabi P, Merkel PA, Jones RB, Pepper RJ, Salama AD, Derebail VK, Milman N, Junek M

Kidney Medicine20244 citations

DOI: 10.1016/j.xkme.2024.100858

06

CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

Turgeon D, Bakowsky V, Baldwin C, Cabral DA, Clements-Baker M, Clifford A, Tervaert JWC, Dehghan N, Ennis D, Famorca L

Rheumatology202322 citations

DOI: 10.1093/rheumatology/kead087

07

Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic.

Goldhar HA, Gazel U, Ivory C, Maltez N, Humphrey-Murto S, Milman N, Zehra Aydin S

Clinical rheumatology2022

DOI: 10.1007/s10067-022-06182-3 PMID: 35513759

08

Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study

Massicotte-Azarniouch D, Petrcich W, Walsh M, Canney M, Hundemer GL, Milman N, Hladunewich MA, Fairhead T, Sood MM

CKJ: Clinical Kidney Journal202237 citations

DOI: 10.1093/ckj/sfab229

09

CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update

Mendel A, Ennis D, Go E, Bakowsky V, Baldwin C, Benseler SM, Cabral DA, Carette S, Clements-Baker M, Clifford AH

Journal of Rheumatology202150 citationsOpen Access

DOI: 10.3899/jrheum.200721 PMID: W3087668140

10

Efficacy of leflunomide in the treatment of vasculitis

Mustapha N, Barra L, Carette S, Cuthbertson D, Khalidi NA, Koening CL, Langford CA, McAlear CA, Milman N, Moreland LW

Clinical and Experimental Rheumatology202127 citations

DOI: 10.55563/clinexprheumatol/ve38dj

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot

Co-investigatorCIHR2023Project Grant

Principal investigators: Walsh, Michael W; Massicotte-Azarniouch, David; Mendel, Arielle

Keywords: Anca; Autoimmune Disease; Dialysis; Kidney Failure; Kidney Function; Vasculitis

$520,200

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Department of Medicine
School of Epidemiology and Public Health
Epidemiology and Public Health
Pediatrics
Medicine/Nephrology
Nephrology
Other

Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Peter Tugwell

School of Epidemiology and Public Health

3 shared papers, latest 2019

Beverley Shea

Epidemiology and Public Health

2 shared papers, latest 2019

Todd Fairhead

Department of Medicine

1 shared papers, latest 2022

Munir Boodhwani

Cardiac Surgery

1 shared papers, latest 2019

Heather Reich

Medicine/Nephrology

1 shared papers, latest 2015

Susanne Benseler

Community Health Sciences

1 shared papers, latest 2015

Ayub Akbari

Department of Medicine

1 shared papers, latest 2025

Jacob Karsh

Department of Medicine

1 shared papers, latest 2010

Michael Walsh

Faculty

1 shared papers, latest 2016

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Milman, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Nataliya Milman

Research

Latest papers

Latest funding

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

The impact of virtual rheumatology care on patient outcomes and hospital admissions: an ambispective study.

Positive Anti-Glomerular Basement Membrane and Proteinase 3-Antineutrophil Cytoplasmic Autoantibody in Infective Endocarditis-Associated Glomerulonephritis: A Diagnostic Challenge.

Glucocorticoid Dosing and Outcomes in ANCA-Associated Vasculitis With Kidney Involvement

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians

CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic.

Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study

CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update

Efficacy of leflunomide in the treatment of vasculitis

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot

Frequent collaborators

Nader Khalidi

Lillian Barra

Leilani Famorca

Michael Walsh

Gerard Cox

Arielle Mendel

Peter Tugwell

Beverley Shea

Mats Junek

Nancy Maltez

Todd Fairhead

Sasha Bernatsky

Munir Boodhwani

Heather Reich

Michael Walsh

Susanne Benseler

David Cabral

Ayub Akbari

Jacob Karsh

Dipayan Chaudhuri

Michael Walsh

Nataliya Milman

Research

Latest papers

Latest funding

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

The impact of virtual rheumatology care on patient outcomes and hospital admissions: an ambispective study.

Positive Anti-Glomerular Basement Membrane and Proteinase 3-Antineutrophil Cytoplasmic Autoantibody in Infective Endocarditis-Associated Glomerulonephritis: A Diagnostic Challenge.

Glucocorticoid Dosing and Outcomes in ANCA-Associated Vasculitis With Kidney Involvement

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians

CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

Factors affecting patient satisfaction with outpatient rheumatology phone&#xa0;visits during the COVID-19 pandemic.

Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study

CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update

Efficacy of leflunomide in the treatment of vasculitis

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot

Frequent collaborators

Nader Khalidi

Lillian Barra

Leilani Famorca

Michael Walsh

Gerard Cox

Arielle Mendel

Peter Tugwell

Beverley Shea

Mats Junek

Nancy Maltez

Todd Fairhead

Sasha Bernatsky

Munir Boodhwani

Heather Reich

Michael Walsh

Susanne Benseler

David Cabral

Ayub Akbari

Jacob Karsh

Dipayan Chaudhuri

Michael Walsh

Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic.